CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing pharmaceutical outsourcing
4.1.2. Innovations in label-free detection technologies
4.1.3. Rising expenditure on research and development by biopharma companies
4.2. Market Restraints & Challenges
4.2.1. Lack of skilled professionals
4.2.2. Rising cost of instruments
4.3. Market Opportunities
4.3.1. Development of more sensitive label-free technologies
4.3.2. Growing life science research activities in emerging markets
CHAPTER 5. GLOBAL LABEL-FREE DETECTION MARKET – BY PRODUCT
5.1. Introduction
5.2. Instruments
5.3. Consumables
5.3.1. Biosensor chips
5.3.2. Microplates
CHAPTER 6. GLOBAL LABEL-FREE DETECTION MARKET – BY TECHNOLOGY
6.1. Introduction
6.2. Differential scanning calorimetry
6.3. Bio-layer interferometry
6.4. Isothermal titration calorimetry
6.5. Surface plasmon resonance
6.6. Other LFD technologies
CHAPTER 7. GLOBAL LABEL-FREE DETECTION MARKET – BY APPLICATION
7.1. Introduction services
7.2. Binding thermodynamics
7.3. Binding kinetics
7.4. Endogenous receptor detection
7.5. Lead generation
7.6. Hit confirmation
7.7. Other applications
CHAPTER 8. GLOBAL LABEL-FREE DETECTION MARKET - BY END USER
8.1. Introduction
8.2. Pharmaceutical & biotechnology companies
8.3. Academic &research institutes
8.4. Contract research organisations (CROs)
8.5. Other end users
CHAPTER 9. GLOBAL LABEL-FREE DETECTION MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL LABEL-FREE DETECTION MARKET - COMPANY
PROFILES
10.1.General Electric
10.2. Hitachi High-Technologies Corporation.
10.3.Shimadzu Corporation.
10.4. Horiba, Ltd.
10.5. Corning Incorporated
10.6. TA Instruments, Inc.
10.7. Malvern Panalytical
10.8. Roche Holding AG.
10.9. AMETEK, Inc.
10.10. PerkinElmer, Inc.,
10.11. Danaher Corporation.
10.12. Apollo Munich Health Insurance.
10.13. International Medical Group.
10.14. UnitedHealth Group Inc.
10.15. Allianz SE.
CHAPTER 11. GLOBAL LABEL-FREE DETECTION MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3.Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
